RU2012117014A - METHOD FOR PRODUCING RECOMBINANT CAPSIDE PROTEIN OF HEPATITIS VIRUS E. RECOMBINANT VACCINE FOR PREVENTION OF VIRAL HEPATITIS E. - Google Patents
METHOD FOR PRODUCING RECOMBINANT CAPSIDE PROTEIN OF HEPATITIS VIRUS E. RECOMBINANT VACCINE FOR PREVENTION OF VIRAL HEPATITIS E. Download PDFInfo
- Publication number
- RU2012117014A RU2012117014A RU2012117014/10A RU2012117014A RU2012117014A RU 2012117014 A RU2012117014 A RU 2012117014A RU 2012117014/10 A RU2012117014/10 A RU 2012117014/10A RU 2012117014 A RU2012117014 A RU 2012117014A RU 2012117014 A RU2012117014 A RU 2012117014A
- Authority
- RU
- Russia
- Prior art keywords
- recombinant
- protein
- hepatitis
- orf2
- rthev
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
1. Способ получения рекомбинантного капсидного белка вируса гепатита Е генотипа 3 (rtHEV-ORF2), включающий культивирование штамма-продуцента, содержащего последовательность ДНК, кодирующую белок ORF2, в подходящих для экспрессии указанного белка условиях, выделение и очистку целевого белка, отличающийся тем, что культивируют рекомбинантный штамм дрожжей Hansenula polymorpha КБТ-11/pHEV-001, содержащий интегрированную в геном последовательность ДНК, включающую рекомбинантный ген, кодирующий полипептид rtHEV-ORF2 с аминокислотной последовательностью SEQ ID NO:1, под контролем промотора гена МОХ Hansenula polymorpha и ген LEU2 S.cerevisiae в качестве селективного маркера, а после выделения и очистки получают белок rtHEV-ORF2 в виде VLP, состоящей из мономеров с молекулярной массой мономера 56 кДа.2. Рекомбинантная вакцина для профилактики вирусного гепатита Е, содержащая эффективное количество капсидного белка вируса гепатита Е, адъювант и физиологически приемлемый разбавитель, отличающаяся тем, что в качестве антигена вируса гепатита Е вакцина содержит белок rtHEV-ORF2, полученный по способу п.1.3. Рекомбинантная вакцина по п.2, отличающаяся тем, что дополнительно содержит мертиолят.1. A method of producing a recombinant hepatitis E virus capsid protein of genotype 3 (rtHEV-ORF2), comprising cultivating a producer strain containing a DNA sequence encoding an ORF2 protein under conditions suitable for expression of said protein, isolating and purifying the target protein, characterized in that cultivate a recombinant strain of Hansenula polymorpha KBT-11 / pHEV-001 containing the DNA sequence integrated into the genome, including the recombinant gene encoding the rtHEV-ORF2 polypeptide with the amino acid sequence of SEQ ID NO: 1, under warning light gene promoter and MOX Hansenula polymorpha LEU2 S.cerevisiae gene as a selectable marker, and after isolation and purification rtHEV-ORF2 protein in a VLP, consisting of monomers with a molecular mass of 56 kDa.2 monomer. Recombinant vaccine for the prevention of viral hepatitis E, containing an effective amount of the capsid protein of the hepatitis E virus, an adjuvant and a physiologically acceptable diluent, characterized in that the vaccine contains the rtHEV-ORF2 protein obtained by the method of clause 1.3 as an antigen of the hepatitis E virus. The recombinant vaccine according to claim 2, characterized in that it further comprises thiolate.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012117014/10A RU2501809C1 (en) | 2012-04-27 | 2012-04-27 | Method for obtaining recombinant core protein of hepatitis e virus and recombinant vaccine for prophylaxis of hepatitis e virus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012117014/10A RU2501809C1 (en) | 2012-04-27 | 2012-04-27 | Method for obtaining recombinant core protein of hepatitis e virus and recombinant vaccine for prophylaxis of hepatitis e virus |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2012117014A true RU2012117014A (en) | 2013-11-10 |
RU2501809C1 RU2501809C1 (en) | 2013-12-20 |
Family
ID=49516484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012117014/10A RU2501809C1 (en) | 2012-04-27 | 2012-04-27 | Method for obtaining recombinant core protein of hepatitis e virus and recombinant vaccine for prophylaxis of hepatitis e virus |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2501809C1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023231149A1 (en) * | 2022-05-25 | 2023-12-07 | Xuzhou Medical University | Recombinant orthohepevirus genotype c1 orf2 protein and preparation method therefor and use thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2745558C2 (en) * | 2016-12-27 | 2021-03-29 | Федеральное государственное бюджетное научное учреждение "Федеральный научный центр исследований и разработки иммунобиологических препаратов им. М.П. Чумакова РАН" | Method of producing recombinant capsid protein of hepatitis e virus |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6291641B1 (en) * | 1988-06-17 | 2001-09-18 | Genelabs Technologies, Inc. | Hepatitis E virus antigens and uses therefor |
US6455492B1 (en) * | 1988-06-17 | 2002-09-24 | Genelabs Technologies, Inc. | Hepatitis E virus vaccine and method |
US6458562B1 (en) * | 1998-04-09 | 2002-10-01 | The United States Of America As Represented By The Secretary Of Health And Human Services | Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
RU2252748C1 (en) * | 2004-02-11 | 2005-05-27 | Солонский Александр Владимирович | Method for treating viral hepatitis |
CN101062941A (en) * | 2007-04-27 | 2007-10-31 | 东南大学 | Recombined hepatitis E hepatitis virus protein, preparation method and usage thereof |
-
2012
- 2012-04-27 RU RU2012117014/10A patent/RU2501809C1/en active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023231149A1 (en) * | 2022-05-25 | 2023-12-07 | Xuzhou Medical University | Recombinant orthohepevirus genotype c1 orf2 protein and preparation method therefor and use thereof |
Also Published As
Publication number | Publication date |
---|---|
RU2501809C1 (en) | 2013-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2017522907A5 (en) | ||
JP2022066209A (en) | High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs | |
EP2493912B1 (en) | High titer recombinant influenza viruses with enhanced replication in vero cells | |
HRP20171213T1 (en) | RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPs) | |
RU2019139064A (en) | Compositions and methods for the treatment of cytomegalovirus | |
RU2014129788A (en) | HPV VACCINES | |
JP2012530499A5 (en) | ||
CA2762042A1 (en) | Chimeric influenza virus-like particles comprising hemagglutinin | |
WO2016116398A1 (en) | A novel vaccine against the middle east respiratory syndrome coronavirus (mers-cov) | |
RU2014116371A (en) | IMPROVEMENT OF VIRUS-LIKE PARTICLES IN PLANTS | |
Dijkman et al. | Human coronaviruses 229E and NL63: close yet still so far | |
RU2013154698A (en) | Obtaining a virus-like particle of the rabies virus in plants | |
TWI695842B (en) | Flavivirus virus like particle | |
JP2015119730A5 (en) | ||
Choi et al. | Chromatographically-purified capsid proteins of red-spotted grouper nervous necrosis virus expressed in Saccharomyces cerevisiae form virus-like particles | |
RU2018130683A (en) | ATTENUATED INFECTIOUS BRONCHITIS VIRUS | |
JP2007516696A5 (en) | ||
CN105821010B (en) | Recombinant NDV for expressing chicken IBDV antibody and application thereof in preparation of bivalent vaccine | |
CN1730101A (en) | O type foot-and-mouth disease virus poly-gene duplication defect type adenovirus active carrier vaccine and preparation method | |
CN103627718A (en) | S1 and N double-antigen protein recombinant plasmid capable of expressing IBV (Infectious Bronchitis Virus) and construction method and application thereof | |
RU2015113826A (en) | ISOLATION OF VIRUS RELATED TO PARVOVIRUS-2 DOGS, FROM RACON | |
JP2022551805A (en) | Recombinant Influenza Virus with Stabilized HA for Intraovo Replication | |
RU2015115898A (en) | NEW MVA VIRUS AND ITS APPLICATIONS | |
RU2012117014A (en) | METHOD FOR PRODUCING RECOMBINANT CAPSIDE PROTEIN OF HEPATITIS VIRUS E. RECOMBINANT VACCINE FOR PREVENTION OF VIRAL HEPATITIS E. | |
RU2012149036A (en) | PARAPOXVIRUS VECTORS CONTAINING THE RAGES VIRUS ANTIGEN |